Volume 29, Issue 1 e70022
ORIGINAL ARTICLE

Fate of Semilunar Valves From Discarded Hearts at the Time of Pediatric Heart Retransplantation

Landon Arcadi

Landon Arcadi

The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA

Search for more papers by this author
Muhammad Faateh

Muhammad Faateh

The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA

Search for more papers by this author
Muhammad Aanish Raees

Muhammad Aanish Raees

The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA

Search for more papers by this author
David L. S. Morales

David L. S. Morales

The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA

Search for more papers by this author
Benjamin S. Mantell

Benjamin S. Mantell

The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA

Search for more papers by this author
Awais Ashfaq

Corresponding Author

Awais Ashfaq

The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA

Correspondence:

Awais Ashfaq ([email protected])

Search for more papers by this author
First published: 08 January 2025
Citations: 2

Funding: The authors received no specific funding for this work.

Submitted as an abstract to the 45th International Society of Heart and Lung Transplantation annual meeting.

ABSTRACT

Background

Partial heart transplantation (PHT) is a novel procedure for children in need of a growing valve replacement option. One challenge is identifying suitable donor valves. Semilunar heart valves from patients receiving a retransplant may be a source, however their functionality and growth potential especially at the time of retransplant are unknown. We aimed to assess growth and function of these valves.

Methods

Data from patients undergoing a retransplant at a single institution were analyzed. Echocardiograms were compared following the primary transplant and immediately before retransplant to assess growth and valve function.

Results

Thirteen patients were included. Recipient and donor ages at the primary transplant were median (range): 2 years (0–13) and 3 years (0–40), respectively. The median time to retransplant was 11 years (2–21). There was an overall growth across all semilunar valve measurements; aortic valve annulus diameter (mean increase ± standard deviation): 0.2 ± 0.12 cm, aortic root: 0.29 ± 0.16 cm, and pulmonary valve annulus: 0.5 ± 0.34 cm; all p < 0.05. The growth rate of valves was higher in younger patients and showed a better correlation with graft age relative to recipient age: aortic valve annulus growth R2: 0.61 (graft age) versus 0.54 (recipient age); aortic root R2: 0.73 versus 0.57; pulmonary valve annulus R2: 0.94 versus 0.86. No patients had clinically significant regurgitation or stenosis on the latest echocardiogram. All except one patient's measurement had valve Z-scores within ±2 at retransplant.

Conclusion

Explanted hearts from patients undergoing retransplantation could be considered an additional source of semilunar valves for PHT. Valves from these hearts were found to function normally and grew in proportion with the recipient's body. Valves from younger donors/recipients demonstrated a more rapid growth rate.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.